186574790	186574790	CD	B-NP	O
|	|	NN	I-NP	O
EGCH	EGCH	NN	I-NP	O
|	|	NN	I-NP	O
02617362	02617362	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2411216	2411216	CD	B-NP	O
|	|	CC	I-NP	O
2/27/2005	2/27/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
upper	upper	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/8/2005	9/8/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/13/2005	10/13/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
FRIBERG	FRIBERG	NN	B-NP	O
,	,	,	O	O
EARL	EARL	NN	B-NP	O
419-46-14-5	419-46-14-5	CD	I-NP	O
Tor	Tor	NNP	I-NP	O
E	E	NNP	I-NP	O
Ran	Ran	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
6/9/05	6/9/05	CD	B-NP	O
AT	AT	NN	I-NP	O
09	09	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TRANTHAM	TRANTHAM	NNP	B-NP	O
,	,	,	O	O
SEBASTIAN	SEBASTIAN	NNP	B-NP	O
ROBBIE	ROBBIE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
INHALER	INHALER	NNP	I-NP	O
4	4	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
Q2H	Q2H	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
September	September	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Shortness	Shortness	NNP	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
ECASA	ECASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ADVIL	ADVIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IBUPROFEN	IBUPROFEN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
110	110	CD	B-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
HO	HO	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/27/05	11/27/05	CD	B-NP	O
by	by	IN	B-PP	O
MCCHRISTION	MCCHRISTION	NN	B-NP	O
,	,	,	O	O
RALEIGH	RALEIGH	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
84565150	84565150	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LOPRESSOR	LOPRESSOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
110	110	CD	B-NP	O
,	,	,	O	O
ht	ht	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
-	-	HYPH	I-NP	O
call	call	NN	I-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
held	hold	VBN	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

FLOVENT	FLOVENT	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FLUTICASONE	FLUTICASONE	NN	I-NP	I-protein
PROPIONATE	PROPIONATE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
880	880	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
MICONAZOLE	MICONAZOLE	NNP	I-NP	I-protein
200MG	200MG	NNP	I-NP	I-protein
VAGINAL	VAGINAL	NNP	I-NP	I-protein
SUPP	SUPP	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
SUPP	SUPP	NN	I-NP	I-protein
PV	PV	NN	I-NP	I-protein
QHS	QHS	NN	I-NP	I-protein
X	X	SYM	B-VP	I-protein
5	5	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
Instructions	Instruction	NNS	I-NP	I-protein
:	:	:	O	I-protein
total	total	JJ	B-NP	I-protein
7	7	CD	I-NP	I-protein
day	day	NN	I-NP	I-protein
course	course	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
started	start	VBD	B-VP	O
3/2	3/2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
750	750	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
14	14	CD	B-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
;	;	:	O	O
started	start	VBD	B-VP	O
7/18/05	7/18/05	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

MICONAZOLE	MICONAZOLE	NN	B-NP	O
NITRATE	NITRATE	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
POWDER	POWDER	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
NEXIUM	NEXIUM	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
GLYBURIDE	GLYBURIDE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Shortness	Shortness	NNP	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
,	,	,	O	O
Wheezing	Wheezing	NNP	B-NP	O
ROBITUSSIN	ROBITUSSIN	NNP	I-NP	O
DM	DM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GUAIFENESIN	GUAIFENESIN	NNP	I-NP	O
DM	DM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
cough	cough	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
ambulate	ambulate	VB	B-VP	O
with	with	IN	B-PP	O
rolling	roll	VBG	B-VP	O
walker	walker	NN	B-NP	O
and	and	CC	I-NP	O
assistance	assistance	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Shulthess	Shulthess	NNP	I-NP	O
,	,	,	O	O
call	call	VBP	B-VP	O
979-172-1132	979-172-1132	CD	B-NP	O
for	for	IN	B-PP	O
f/u	f/u	NN	B-NP	O
appt	appt	NN	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
hypercarbic	hypercarbic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
upper	upper	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
TAH	TAH	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diastolic	diastolic	JJ	I-NP	O
CHF	CHF	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OA	OA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
L	L	NN	I-NP	O
ankle	ankle	NN	I-NP	O
edema	edema	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
intubation/ventilatory	intubation/ventilatory	JJ	I-NP	O
support	support	NN	I-NP	O
,	,	,	O	O
BiPAP	BiPAP	NN	B-NP	B-protein
,	,	,	O	O
antibiotics	antibiotic	NNS	B-NP	O
,	,	,	O	O
diuresis	diuresis	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
hypercarbic	hypercarbic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
53	53	CD	B-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
h/o	h/o	NN	I-NP	O
morbid	morbid	NN	I-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	O
p/w	p/w	NN	I-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Developed	Developed	NNP	B-NP	O
URI	URI	NNP	I-NP	O
and	and	CC	O	O
DOE	DOE	NNP	B-NP	O
over	over	IN	B-PP	O
week	week	NN	B-NP	O
PTA	PTA	NN	I-NP	O
.	.	.	O	O

Presented	Present	VBN	B-VP	O
to	to	TO	B-PP	O
PCP	PCP	NN	B-NP	O
4/7	4/7	CD	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
SOB	SOB	NN	I-NP	B-protein
-	-	HYPH	O	O
sats	sat	NNS	B-NP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
4L	4L	NN	I-NP	O
NC	NC	NN	I-NP	O
.	.	.	O	O

Sent	Sent	JJ	B-ADJP	O
to	to	TO	B-PP	O
Merleah	Merleah	NNP	B-NP	O
Center	Center	NNP	I-NP	O
and	and	CC	O	O
given	give	VBN	B-NP	O
solumedrol	solumedrol	NN	I-NP	O
and	and	CC	I-NP	O
nebs	neb	NNS	I-NP	O
;	;	:	O	O
ABG	ABG	NN	B-NP	O
7.18	7.18	CD	I-NP	O
/	/	SYM	I-NP	O
90/58	90/58	CD	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
intubated	intubated	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
FIBEROPTICALLY	FIBEROPTICALLY	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
EHO	EHO	NN	B-NP	B-DNA
MICU	MICU	NN	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
ICU	ICU	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
suffering	suffer	VBG	I-VP	O
from	from	IN	B-PP	O
obesity	obesity	NN	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
decompensastion	decompensastion	NN	B-NP	O
2/2	2/2	CD	I-NP	O
URI	URI	NN	I-NP	O
;	;	:	O	O
+	+	SYM	B-NP	O
/	/	SYM	O	O
-	-	HYPH	O	O
compnent	compnent	NN	B-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Steroids	Steroid	NNS	B-NP	O
stopped	stop	VBD	B-VP	O
;	;	:	O	O
Abx	Abx	NN	B-NP	O
and	and	CC	I-NP	O
gentle	gentle	JJ	I-NP	O
diuretics	diuretic	NNS	I-NP	O
given	give	VBN	B-VP	O
.	.	.	O	O

Extubated	Extubate	VBN	B-VP	O
3/2	3/2	CD	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
nl	nl	NN	B-NP	O
PH	PH	NN	I-NP	O
and	and	CC	O	O
PCO2	PCO2	NN	B-NP	B-protein
70s	70	NNS	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
presumed	presume	VBN	B-NP	I-protein
baseline	baseline	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Unable	Unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
BiPAP	BiPAP	NN	B-NP	B-protein
in	in	IN	B-PP	O
ICU	ICU	NN	B-NP	B-protein
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
97.6	97.6	CD	B-NP	O
,	,	,	I-NP	O
63	63	CD	I-NP	O
,	,	,	I-NP	O
144/75	144/75	CD	I-NP	O
,	,	,	O	O
RR	RR	NNP	B-NP	O
15	15	CD	I-NP	O
,	,	,	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
1L	1L	NN	I-NP	O
.	.	.	O	O

Morbidly	Morbidly	RB	B-NP	O
obese	obese	JJ	I-NP	O
middle-aged	middle-aged	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
,	,	,	O	O
OP	OP	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
MMM	MMM	NN	B-NP	B-protein
,	,	,	O	O
poor	poor	JJ	B-NP	O
dentition	dentition	NN	I-NP	O
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
poor	poor	JJ	B-NP	O
air	air	NN	I-NP	O
movement/coarse	movement/coarse	NN	I-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
S1S2	S1S2	NN	B-NP	B-protein
,	,	,	O	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
hear	hear	VB	I-VP	O
m/r/g	m/r/g	NN	B-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
c	c	NN	I-NP	O
well-healed	well-healed	JJ	I-NP	O
midline	midline	NN	I-NP	O
scar	scar	NN	I-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
obese	obese	NN	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
NT/ND	NT/ND	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
HSM	HSM	NN	I-NP	B-protein
appreciated	appreciate	VBN	B-VP	O
,	,	,	O	O
large/swollen	large/swollen	VBN	B-VP	O
ext	ext	NN	B-NP	O
,	,	,	O	O
NT	NT	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
pitting	pit	VBG	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
per	per	IN	B-PP	O
patient	patient	NN	B-NP	O
,	,	,	O	O
neuro	neuro	NN	B-NP	O
non-focal	non-focal	JJ	B-ADJP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
diastolic	diastolic	JJ	B-NP	O
CHG	CHG	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
TAH/hernia	TAH/hernia	NNP	I-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
OA	OA	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
L	L	NN	I-NP	O
ankle	ankle	NN	I-NP	O
edema	edema	NN	I-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
25	25	CD	I-NP	O
QID	QID	NNP	I-NP	O
,	,	,	O	O
Lovenox	Lovenox	NNP	B-NP	O
SC	SC	NNP	I-NP	O
,	,	,	O	O
Levoflox	Levoflox	NNP	B-NP	O
750	750	CD	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	I-NP	O
Lantus	Lantus	NNP	I-NP	O
5	5	CD	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NN	I-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
levo	levo	NN	B-NP	O
for	for	IN	B-PP	O
CAP	CAP	NN	B-NP	B-protein
x	x	SYM	O	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
;	;	:	O	O
Gentle	Gentle	NN	B-NP	O
O2	O2	NN	I-NP	O
to	to	TO	B-VP	O
support	support	VB	I-VP	O
O2	O2	NN	B-NP	O
sats	sat	NNS	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
goal	goal	NN	I-NP	O
sat	sit	VBD	B-VP	O
~	~	IN	B-ADVP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
pt	pt	NN	B-NP	O
tolerated	tolerate	VBD	B-VP	O
BiPAP	BiPAP	NN	B-NP	B-protein
on	on	IN	B-PP	O
floor	floor	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
BiPAP	BiPAP	NN	I-NP	O
for	for	IN	B-PP	O
hypoventilation	hypoventilation	NN	B-NP	O
2/2	2/2	CD	I-NP	O
morbid	morbid	NN	I-NP	O
obesity	obesity	NN	I-NP	O
;	;	:	O	O
d/c	d/c	NN	B-NP	O
'd	'd	MD	B-VP	O
w	w	VB	I-VP	O
/	/	SYM	B-NP	B-protein
Abx	Abx	NN	I-NP	I-protein
,	,	,	O	O
lasix	lasix	NN	B-NP	O
for	for	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
of	of	IN	B-PP	O
euvolemia	euvolemia	NN	B-NP	O
,	,	,	O	O
inhalers	inhaler	NNS	B-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
;	;	:	O	O
MS	MS	NN	B-NP	O
no	no	DT	B-NP	O
rmal	rmal	JJ	I-NP	O
on	on	IN	B-PP	O
d/c	d/c	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
levo	levo	NN	B-NP	O
x	x	CC	O	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
micro	micro	NN	I-NP	I-protein
data	datum	NNS	I-NP	I-protein
3	3	CD	B-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
or	or	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
issues	issue	NNS	I-NP	O
;	;	:	O	O
lasix	lasix	NN	B-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
euvolemic	euvolemic	JJ	B-NP	O
s/p	s/p	NN	I-NP	O
diuresis	diuresis	NN	I-NP	O
in	in	IN	B-PP	O
ICU	ICU	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	O
ENDO	ENDO	NN	I-NP	O
:	:	:	O	O
lantus/NPH	lantus/NPH	NN	B-NP	O
during	during	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
;	;	:	O	O
d/c	d/c	NN	B-NP	O
'd	'd	VBD	B-VP	O
on	on	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
-	-	HYPH	B-NP	O
adjust	adjust	JJ	I-NP	O
and	and	CC	I-NP	O
further	further	JJ	I-NP	O
DM	DM	NN	I-NP	O
work-up	work-up	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
DM	DM	NN	I-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
FEN	FEN	NN	I-NP	O
:	:	:	O	O
low	low	JJ	B-NP	O
fat/low	fat/low	NN	I-NP	O
salt	salt	NN	I-NP	O
diet	diet	NN	I-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DISPO	DISPO	NN	I-NP	O
:	:	:	O	O
seen	see	VBN	B-VP	O
by	by	IN	B-PP	O
PT	PT	NN	B-NP	O
;	;	:	O	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
rehab	rehab	NN	I-NP	O
;	;	:	O	O
OK	OK	NN	B-NP	O
for	for	IN	B-PP	O
d/c	d/c	NN	B-NP	O
home	home	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
and	and	CC	I-NP	O
BiPAP	BiPAP	NN	I-NP	B-protein
;	;	:	O	O
lives	live	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
son	son	NN	I-NP	O
FULL	FULL	NN	I-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
;	;	:	O	O
see	see	VB	B-VP	O
a	a	DT	B-NP	O
physician	physician	NN	I-NP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
excessive	excessive	JJ	B-NP	O
sleepiness	sleepiness	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
assist	assist	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
meds	med	NNS	I-NP	O
;	;	:	O	O
please	please	NN	B-NP	O
provide	provide	VBP	B-VP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	B-protein
PT	PT	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ambulate	ambulate	VBP	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
rolling	rolling	NN	I-NP	O
walker	walker	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
please	please	NN	B-NP	O
provide	provide	VBP	B-VP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
and	and	CC	I-NP	O
home	home	NN	I-NP	O
BiPAP	BiPAP	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
setting	set	VBG	B-VP	O
10/5	10/5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
please	please	VB	B-VP	O
assess	assess	NN	B-NP	O
respiratory	respiratory	JJ	I-NP	O
and	and	CC	I-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
each	each	DT	B-NP	O
visit	visit	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
f/u	f/u	SYM	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
PCP	PCP	NN	I-NP	O
;	;	:	O	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
interventions	intervention	NNS	I-NP	O
;	;	:	O	O
home	home	NN	B-NP	O
BiPAP	BiPAP	NN	I-NP	O
and	and	CC	I-NP	O
O2	O2	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BUCHOLTZ	BUCHOLTZ	NNP	B-NP	O
,	,	,	O	O
OLLIE	OLLIE	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GP10	GP10	NNP	I-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	O
6/9/05	6/9/05	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
22	22	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

